Azienda Ospedaliero Universitaria di Bologna
Welcome,         Profile    Billing    Logout  
 4 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Barbara, Giovanni
NCT04691895: Gastrointestinal Symptoms in COVID-19

Active, not recruiting
N/A
2000
Europe
SARS-CoV2 infection
University of Bologna
COVID19 Disease
09/20
12/21
NCT05016024: Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.

Completed
N/A
71
Europe
Colilen IBS, Placebo
Aboca Spa Societa' Agricola, IQVIA RDS, IQVIA Solutions
Irritable Bowel Syndrome
02/23
02/23
GIANT, NCT06681012: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Recruiting
N/A
330
Europe
Gelsectan®, Placebo
Devintec Sagl
Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
11/25
11/25
NCT06799793: Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer

Recruiting
N/A
1400
Europe
GI Genius, artificial intelligence, Colonscope Olympus, Colonscope
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Colorectal Cancer, Screening
12/26
12/26
Gambineri, Alessandra
NCT06484868: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Recruiting
4
12
Europe
Metreleptin
Amryt Pharma
Partial Lipodystrophy
09/27
09/27
SPIOMET4HEALTH, NCT05394142 / 2021-003177-58: A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

Recruiting
2
364
Europe, RoW
Placebo, Pioglitazone, PIO, Spironolactone, S, Metformin, MET
Fundació Sant Joan de Déu
Polycystic Ovary Syndrome (PCOS)
04/25
04/25
NCT06754423: Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

Recruiting
N/A
30
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Congenital Adrenal Hyperplasia
06/32
12/32
NCT06794190: Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants

Recruiting
N/A
120
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Turner Syndrome
01/26
01/26
MEASuRE, NCT02325674: Metreleptin Effectiveness And Safety Registry

Recruiting
N/A
100
Europe, US
Metreleptin
Aegerion Pharmaceuticals, Inc.
Generalised Lipodystrophy, Partial Lipodystrophy
10/31
10/31
ECLip Registry, NCT03553420: Registry for Patients With Lipodystrophy

Recruiting
N/A
5000
Europe, RoW
University of Ulm, Sorbonne University, University Hospital, Lille, University of Cambridge, Endocrinology Research Centre, Moscow, University of Leipzig, University of Amsterdam, Dokuz Eylul University, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Rome Tor Vergata, University of Pisa, University of Santiago de Compostela, Università degli Studi del Piemonte Orientale Amedeo Avogadro, University Hospital Muenster, Szeged University, Centro Hospitalar do Porto, University Medical Centre Ljubljana, Medical University of Vienna, Ostschweizer Kinderspital
Lipodystrophy Acquired, Lipodystrophy Congenital
01/68
01/68
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Barbara, Giovanni
NCT04691895: Gastrointestinal Symptoms in COVID-19

Active, not recruiting
N/A
2000
Europe
SARS-CoV2 infection
University of Bologna
COVID19 Disease
09/20
12/21
NCT05016024: Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.

Completed
N/A
71
Europe
Colilen IBS, Placebo
Aboca Spa Societa' Agricola, IQVIA RDS, IQVIA Solutions
Irritable Bowel Syndrome
02/23
02/23
GIANT, NCT06681012: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Recruiting
N/A
330
Europe
Gelsectan®, Placebo
Devintec Sagl
Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
11/25
11/25
NCT06799793: Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer

Recruiting
N/A
1400
Europe
GI Genius, artificial intelligence, Colonscope Olympus, Colonscope
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Colorectal Cancer, Screening
12/26
12/26
Gambineri, Alessandra
NCT06484868: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Recruiting
4
12
Europe
Metreleptin
Amryt Pharma
Partial Lipodystrophy
09/27
09/27
SPIOMET4HEALTH, NCT05394142 / 2021-003177-58: A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

Recruiting
2
364
Europe, RoW
Placebo, Pioglitazone, PIO, Spironolactone, S, Metformin, MET
Fundació Sant Joan de Déu
Polycystic Ovary Syndrome (PCOS)
04/25
04/25
NCT06754423: Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

Recruiting
N/A
30
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Congenital Adrenal Hyperplasia
06/32
12/32
NCT06794190: Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants

Recruiting
N/A
120
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Turner Syndrome
01/26
01/26
MEASuRE, NCT02325674: Metreleptin Effectiveness And Safety Registry

Recruiting
N/A
100
Europe, US
Metreleptin
Aegerion Pharmaceuticals, Inc.
Generalised Lipodystrophy, Partial Lipodystrophy
10/31
10/31
ECLip Registry, NCT03553420: Registry for Patients With Lipodystrophy

Recruiting
N/A
5000
Europe, RoW
University of Ulm, Sorbonne University, University Hospital, Lille, University of Cambridge, Endocrinology Research Centre, Moscow, University of Leipzig, University of Amsterdam, Dokuz Eylul University, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Rome Tor Vergata, University of Pisa, University of Santiago de Compostela, Università degli Studi del Piemonte Orientale Amedeo Avogadro, University Hospital Muenster, Szeged University, Centro Hospitalar do Porto, University Medical Centre Ljubljana, Medical University of Vienna, Ostschweizer Kinderspital
Lipodystrophy Acquired, Lipodystrophy Congenital
01/68
01/68

Download Options